[go: up one dir, main page]

CA1085729A - Procede et compose pour le traitement de la leucemie et d'autres tumeurs - Google Patents

Procede et compose pour le traitement de la leucemie et d'autres tumeurs

Info

Publication number
CA1085729A
CA1085729A CA273,253A CA273253A CA1085729A CA 1085729 A CA1085729 A CA 1085729A CA 273253 A CA273253 A CA 273253A CA 1085729 A CA1085729 A CA 1085729A
Authority
CA
Canada
Prior art keywords
deazaminopterin
pharmaceutical composition
leukemia
pharmaceutically acceptable
ascites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA273,253A
Other languages
English (en)
Inventor
Joseph I. De Graw
Francis M. Sirotnak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SRI International Inc
Original Assignee
SRI International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SRI International Inc filed Critical SRI International Inc
Application granted granted Critical
Publication of CA1085729A publication Critical patent/CA1085729A/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA273,253A 1976-03-05 1977-03-04 Procede et compose pour le traitement de la leucemie et d'autres tumeurs Expired CA1085729A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66421376A 1976-03-05 1976-03-05
US664,213 1976-03-05

Publications (1)

Publication Number Publication Date
CA1085729A true CA1085729A (fr) 1980-09-16

Family

ID=24665062

Family Applications (1)

Application Number Title Priority Date Filing Date
CA273,253A Expired CA1085729A (fr) 1976-03-05 1977-03-04 Procede et compose pour le traitement de la leucemie et d'autres tumeurs

Country Status (10)

Country Link
JP (1) JPS52120134A (fr)
AU (1) AU511856B2 (fr)
BE (1) BE852095A (fr)
CA (1) CA1085729A (fr)
DE (1) DE2709506C2 (fr)
FR (1) FR2342732A1 (fr)
GB (1) GB1534238A (fr)
IE (1) IE45338B1 (fr)
IL (1) IL51593A (fr)
ZA (1) ZA771315B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393064A (en) * 1976-03-05 1983-07-12 Sri International Process and composition for treatment of leukemia and process for preparing the same
US4460591A (en) * 1982-08-26 1984-07-17 Sri International 8,10-Dideazaminopterins
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US4833145A (en) * 1986-06-30 1989-05-23 The Trustees Of Princeton University 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4996206A (en) * 1989-12-11 1991-02-26 The Trustees Of Princeton University N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
AU1223400A (en) * 1998-10-22 2000-05-08 Phillip B. B. Moheno Novel pterin antineoplastic agents

Also Published As

Publication number Publication date
IE45338B1 (en) 1982-08-11
GB1534238A (en) 1978-11-29
FR2342732A1 (fr) 1977-09-30
IL51593A0 (en) 1977-05-31
BE852095A (fr) 1977-07-01
AU511856B2 (en) 1980-09-11
IL51593A (en) 1980-01-31
DE2709506C2 (de) 1987-03-26
AU2292677A (en) 1978-09-07
IE45338L (en) 1977-09-05
JPS52120134A (en) 1977-10-08
DE2709506A1 (de) 1977-09-08
FR2342732B1 (fr) 1980-02-01
ZA771315B (en) 1978-05-30
JPS613325B2 (fr) 1986-01-31

Similar Documents

Publication Publication Date Title
US8530507B2 (en) Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs
CA1085729A (fr) Procede et compose pour le traitement de la leucemie et d'autres tumeurs
US6833478B2 (en) N,N-dinitramide salts as solubilizing agents for biologically active agents
CN101084886A (zh) 联合化学疗法
US3885035A (en) Method for treating arrhythmia by using 1,4-bis(4 quinazolinyl) piperazines
CZ281577B6 (cs) Způsob přípravy přípravků ve formě tablet nebo dražé, obsahujících účinnou látku citlivou na světlo,teplo a vlhkost, mající monoklinickou krystalovou strukturu
KR100456831B1 (ko) 메타아르세나이트을 함유한 항암제 조성물
Dixon Effect of chloramphenicol on the metabolism and lethality of cyclophosphamide in rats
EP1359979B1 (fr) Combinaison anticancereuse de pyrroles substitues et du paclitaxel
WO1999000122A1 (fr) Procede pour reduire le poids du corps
US3027303A (en) Hematinic compositions
US4867978A (en) Method of prolonging cancerous patient survival in humans with hydrazine sulfate
EP0500953A1 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
US4584305A (en) Aiding the regression of neoplastic disease with 2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole
US4931433A (en) Method for treating certain neoplastic diseases
Rodriguez et al. Phase 2 study with Baker's antifol in solid tumors
US4006235A (en) Treating CNS lymphoma
US4005204A (en) Treatment of neoplasms in the brain with diamino dichloroalkyl pyrimidine
US4329346A (en) Pharmaceutical compositions containing 2,6-bis-(diethanolamino)-4-piperidino-pyrimido[5,4-d]pyrimidine
US3152041A (en) Piperazine-bithionol anthelmintic
US4005203A (en) Treatment of meningeal leukemia with diamino dichlorophenyl pyrimidine
USRE23947E (en) Process of and compositions for
Machover et al. With 5-Fluorouracil and High-Dose Folinic Acid¹
US3506765A (en) Method for the relief of cough with a thebaine derivative
RU2279277C2 (ru) Лечение разделенными дозами агентов с сосудоразрушающей активностью

Legal Events

Date Code Title Description
MKEX Expiry